Low Serum Testosterone Concentration in Middle-aged Men with Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Low concentrations of endogenous androgens have been linked with insulin resistance and atherosclerosis. Men with diabetes have been reported to have lower serum testosterone concentration than non-diabetic men; however, there has never been a large study. The aim of this study was to investigate if endogenous androgen concentration is certainly lower in a relatively large number of Japanese patients with type 2 diabetes compared with healthy men, and to identify what factors may be associated with low serum testosterone concentrations in men with type 2 diabetes. Serum free testosterone concentrations were measured in 524 healthy men and in 331 consecutive Japanese men with type 2 diabetes between 40 and 69 years old. In addition, we investigated the relationships between serum free testosterone concentration and luteinizing hormone (LH) concentration as well as major cardiovascular risk factors including age, blood pressure, plasma lipid concentration, glycemic control (HbA(1c)), and BMI. Serum free testosterone concentrations were lower in men with type 2 diabetes than in healthy men in the 40-49 years group (10.9 +/- 3.3 vs. 14.0 +/- 3.6 pg/ml, P<0.0001), in the 50-59 years group (10.4 +/- 3.2 vs. 12.1 +/- 2.9 pg/ml, P<0.0001), and in the 60-69 years group (9.5 +/- 2.6 vs. 10.5 +/- 2.9 pg/ml, P = 0.0104). A negative correlation was found between serum free testosterone and LH concentrations (r = -0.326, P<0.0001). In conclusion, serum free testosterone concentration is certainly lower in a relatively large number of Japanese patients with type 2 diabetes compared with healthy men with each decade of life between 40 and 69 years old.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
Keating, N. L., O'Malley, A. J., & Smith, M. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.2497 · Cited by 1,455
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2847 · Cited by 965
Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes
Dhindsa, S., Prabhakar, S., Sethi, M., Bandyopadhyay, A., Chaudhuri, A., & Dandona, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0804 · Cited by 631 · cited 1×
“[13] demonstrating serum LH concentrations correlated positively with serum free testosterone concentrations (hypogonadotropic hypogonadism) in men with type 2 diabetes.”
Stellato, R. K., Feldman, H. A., Hamdy, O., Horton, E. S., & McKinlay, J. B. (2000) · Diabetes Care · doi:10.2337/diacare.23.4.490 · Cited by 618
Boyanov, M. A., Boneva, Z., & Christov, V. G. (2003) · The Aging Male · doi:10.1080/tam.6.1.1.7 · Cited by 381
Vermeulen, A. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.5.1140 · Cited by 346
Barrett-Connor, E. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-10-807 · Cited by 281
Testosterone concentrations in women and men with NIDDM
Andersson, B., Märin, P., Lissner, L., Vermeulen, A., & Björntorp, P. (1994) · Diabetes Care · doi:10.2337/diacare.17.5.405 · Cited by 268 · cited 1×
“serum testosterone concentrations than non-diabetic men [8, 9].”
Morales, A., & Lunenfeld, B. (2002) · The Aging Male · doi:10.1080/tam.5.2.74.86 · Cited by 266
Simon, D. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.682 · Cited by 220
The influence of aging on plasma sex hormones in men: the Telecom study.
Simon, D., Preziosi, P., Barrett-Connor, E., Roger, M., Saint-Paul, M., Nahoul, K., & Papoz, L. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116365 · Cited by 166 · cited 1×
“The Telecom Study demonstrated a significant decrease in testosterone concentration with each decade of life [26].”
Diabetes mellitus is associated with subnormal serum levels of free testosterone in men
Rhoden, E. L., Ribeiro, E. P., Teloken, C., & Souto, C. A. V. (2005) · BJU International · doi:10.1111/j.1464-410x.2005.05728.x · Cited by 100 · cited 1×
“[22] also demonstrated that subnormal free testosterone concentration had a stronger correlation with the presence of diabetes mellitus than subnormal total testosterone concentration.”
Cited by
The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance
Traish, A. M., Saad, F., & Guay, A. (2009) · Journal of Andrology · doi:10.2164/jandrol.108.005751 · Cited by 266
Prevalence of low testosterone levels in men with type 2 diabetes mellitus: a cross-sectional study
Al Hayek, A., Khader, Y., Jafal, S., Khawaja, N., Robert, A., & Ajlouni, K. (2013) · Journal of Family and Community Medicine · doi:10.4103/2230-8229.122006 · Cited by 94
“In this study, LST was defined as TT 3.0 ng/ml and TT used as reference parameter to define LST. [8,23,24] Symptomatic androgen deficiency was defined as TT <3.0 ng/ml in addition to a positive response to ADAM questionnaire.”
InfluentialCorrelation of sex hormone and androgen receptor with diabetes mellitus in elderly men
Cao, J., Li, J., Hao, W., Li, X., Wang, H., Liu, L., Zhu, B., & Guo, Z. (2011) · The Aging Male · doi:10.3109/13685538.2011.575479 · Cited by 21
“found that free testosterone (FT) concentrations in serum were lower in a relatively large number of Japanese patients with type 2 DM compared with healthy men for each decade of life between 40 and 69 years of age, and the incidence of insulin resistance and atherosclerosis in patients with low concentrations of endo…”
Background
Metadata
- Authors
- FUKUI, M., SOH, J., TANAKA, M., KITAGAWA, Y., HASEGAWA, G., YOSHIKAWA, T., MIKI, T., & NAKAMURA, N.
- Venue
- Endocrine Journal
- Publisher
- Japan Endocrine Society
- Published
- 2007
- Volume
- 54
- Issue
- 6
- Pages
- 871-877
- ISSN
- 0918-8959 (ISSN-L)
- 1348-4540
- OpenAlex
- W2050263294
- Cited by
- 73
- References
- 12
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.